iX Biopharma issues 1.36 million new shares from warrant exercises ahead of July 17 expiry
SGX Filings
Jul 20
iX Biopharma Ltd. said it allotted and issued 1,362,355 new ordinary shares on Jul, 20 2026 following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.
The issuance lifts the company’s total outstanding shares to 1,093,315,474 from 1,091,953,119. The new shares will rank pari passu with existing shares and are expected to start trading on the Singapore Exchange on or around Jul, 22 2026.
All remaining unexercised warrants expired at 5:00 p.m. on Jul, 17 2026, in accordance with the warrant conditions, and are now void.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.